Jazz Pharmaceuticals plc buy Truist Financial Co.
Start price
04.12.23
/
50%
€112.25
Target price
04.12.24
€184.92
Performance (%)
-8.73%
Price
14.05.24
€103.55
Summary
This prediction is currently active. With a performance of -8.73%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 04.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 0.097% | 0.097% |
| iShares Core DAX® | 1.662% | 4.835% |
| iShares Nasdaq 100 | 0.667% | 0.000% |
| iShares Nikkei 225® | -2.139% | -4.786% |
| iShares S&P 500 | 0.564% | 0.775% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $200.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€115.00
20.03.24
20.03.24
€184.14
20.03.25
20.03.25
-9.96%
14.05.24
14.05.24
